PT2389070E - Formulações desintegráveis de carbonato de lantânio - Google Patents
Formulações desintegráveis de carbonato de lantânioInfo
- Publication number
- PT2389070E PT2389070E PT107338311T PT10733831T PT2389070E PT 2389070 E PT2389070 E PT 2389070E PT 107338311 T PT107338311 T PT 107338311T PT 10733831 T PT10733831 T PT 10733831T PT 2389070 E PT2389070 E PT 2389070E
- Authority
- PT
- Portugal
- Prior art keywords
- disintegrable
- lanthanum carbonate
- formulations
- dosage forms
- hyperphosphatemia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/244—Lanthanides; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14616209P | 2009-01-21 | 2009-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2389070E true PT2389070E (pt) | 2013-10-21 |
Family
ID=42356194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT107338311T PT2389070E (pt) | 2009-01-21 | 2010-01-21 | Formulações desintegráveis de carbonato de lantânio |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8962036B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2389070B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5643227B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2748496C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2433076T3 (cg-RX-API-DMAC7.html) |
| PL (1) | PL2389070T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2389070E (cg-RX-API-DMAC7.html) |
| SI (1) | SI2389070T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010085520A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201105577B (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0640812B2 (ja) | 1987-10-28 | 1994-06-01 | 雪印乳業株式会社 | 醗酵室 |
| US8263119B2 (en) | 2010-12-01 | 2012-09-11 | Shire Llc | Capsule formulations containing lanthanum compounds |
| US8697132B2 (en) | 2010-12-01 | 2014-04-15 | Shire Llc | Capsule and powder formulations containing lanthanum compounds |
| WO2016051609A1 (ja) * | 2014-10-02 | 2016-04-07 | 東和薬品株式会社 | 粒度調整された炭酸ランタン水和物からなる医薬 |
| JP2016147827A (ja) * | 2015-02-12 | 2016-08-18 | 株式会社三和化学研究所 | 炭酸ランタン水和物を含有する医薬製剤 |
| CN112724039A (zh) | 2015-04-20 | 2021-04-30 | 艾德凡斯化学公司 | 包括烷基肟的涂料组合物 |
| EP4061340A4 (en) | 2019-11-21 | 2023-08-09 | Santa Farma Ilaç Sanayi A.S. | ORAL SOLID PHARMACEUTICAL COMPOSITIONS WITH LANTANHANE CARBONATE OCTAHYDRATE |
| CN115813867B (zh) * | 2022-12-01 | 2024-05-24 | 山东齐都药业有限公司 | 碳酸镧冻干片及其制备方法 |
| JP2025044388A (ja) * | 2023-09-20 | 2025-04-02 | 株式会社東芝 | 酸性ガス除去方法、酸性ガス吸収剤、および酸性ガス除去装置 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3371531B2 (ja) * | 1994-04-20 | 2003-01-27 | 株式会社豊田中央研究所 | 触媒の製造方法 |
| GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
| GB0123400D0 (en) * | 2001-09-28 | 2001-11-21 | Novartis Ag | Organic compounds |
| US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
| DK2792363T3 (da) * | 2003-08-26 | 2016-09-26 | Shire Biopharmaceuticals Holdings Ireland Ltd | Farmaceutisk formulering, der omfatter lanthanforbindelser |
| US7381428B2 (en) * | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
| WO2007022466A2 (en) * | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Hyperphosphatemia in domestic animals: compositions and methods of treatment |
| GB0612695D0 (en) * | 2006-06-27 | 2006-08-09 | Univ Gent | Process for preparing a solid dosage form |
-
2010
- 2010-01-21 PL PL10733831T patent/PL2389070T3/pl unknown
- 2010-01-21 US US13/145,589 patent/US8962036B2/en not_active Expired - Fee Related
- 2010-01-21 JP JP2011546449A patent/JP5643227B2/ja not_active Expired - Fee Related
- 2010-01-21 WO PCT/US2010/021573 patent/WO2010085520A1/en not_active Ceased
- 2010-01-21 PT PT107338311T patent/PT2389070E/pt unknown
- 2010-01-21 EP EP10733831.1A patent/EP2389070B1/en active Active
- 2010-01-21 CA CA2748496A patent/CA2748496C/en active Active
- 2010-01-21 ES ES10733831T patent/ES2433076T3/es active Active
- 2010-01-21 SI SI201030369T patent/SI2389070T1/sl unknown
-
2011
- 2011-07-28 ZA ZA2011/05577A patent/ZA201105577B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2389070T1 (sl) | 2013-11-29 |
| PL2389070T3 (pl) | 2014-01-31 |
| ES2433076T3 (es) | 2013-12-09 |
| JP5643227B2 (ja) | 2014-12-17 |
| HK1163452A1 (en) | 2012-09-14 |
| EP2389070A1 (en) | 2011-11-30 |
| EP2389070B1 (en) | 2013-07-31 |
| CA2748496A1 (en) | 2010-07-29 |
| US20110280967A1 (en) | 2011-11-17 |
| US8962036B2 (en) | 2015-02-24 |
| WO2010085520A1 (en) | 2010-07-29 |
| EP2389070A4 (en) | 2012-07-11 |
| CA2748496C (en) | 2019-02-26 |
| JP2012515723A (ja) | 2012-07-12 |
| ZA201105577B (en) | 2014-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN06720A (cg-RX-API-DMAC7.html) | ||
| PH12012502083A1 (en) | Manufacturing of active-free granules and tablets comprising the same | |
| MY157673A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| WO2011053653A3 (en) | Prevotella histicola preparations and the treatment of autoimmune conditions | |
| IL214942A (en) | N, n– Dimethyl-5– (2-methyl-6 - ((5-methylpyrazine-2-yl) carbamole) Benzoporen-4-Iloxy) Pyrimidine-2-carboxamide and the salts common in its pharmacies, pharmaceuticals containing them and their uses in the preparation of drugs | |
| UA106634C2 (uk) | Тверда фармацевтична дозована форма | |
| IL218071A0 (en) | Novel pharmaceutical formulations to prevent the misuse of medicinal drugs | |
| WO2011104652A3 (en) | Veterinary compositions | |
| TN2015000135A1 (en) | Modified release formulations for oprozomib | |
| WO2012098562A3 (en) | Liquid oral compositions of lanthanum salts | |
| PH12012502082A1 (en) | Combination of active loaded granules with additional actives | |
| TN2011000651A1 (en) | Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application | |
| PH12014501408A1 (en) | Immediate release multi unit pellet system | |
| TN2012000507A1 (en) | Enteric tablet | |
| WO2011139249A3 (en) | Pharmaceutical composition comprising cefdinir | |
| PH12015500070A1 (en) | Pediatric oral liquid compositions containing nepadutant | |
| EP2863899B8 (en) | Formulations for the preparation of immediate-release tablets for oral use containing low-dose mifepristone for the treatment of endometriosis, tablets thus obtained and their preparation process | |
| NZ707033A (en) | Dispersible nimorazole tablet | |
| ZA201500411B (en) | Formulations for the preparation of immediate-release tablets for oral administration containing low-dose mifepristone, tablets thus obtained and their preparation process | |
| TR200704897A1 (tr) | Uzatılmış salım sağlayan gliklazid formülasyonları@ | |
| SA515360445B1 (ar) | قرص قابل للتشتيت | |
| DK201270714A (en) | Dispersible tablet | |
| UA99317C2 (ru) | Фармацевтическая композиция в форме таблеток для лечения вирусных заболеваний | |
| UA97535C2 (ru) | Лекарственный противоэпилептический препарат леветирацетама в форме таблеток, способ его изготовления и кристаллический состав | |
| UA77604U (ru) | Производное 1,2,4-триазола, проявляющее актопротекторную активность |